Conference
An assessment of safety of daily subcutaneous (SC) injections of kineret (TM) (anakinra-recombinant interleukin-1 receptor antagonist) in a standard practice population of patients with rheumatoid arthritis (RA)
Authors
Choquette D; Russell A; Offer R; Pirc L; Cividino A
Volume
30
Pagination
pp. 1877-1877
Publisher
J RHEUMATOL PUBL CO
Publication Date
August 1, 2003
Name of conference
Annual Meeting of the Canadian-Rheumatology-Association
Conference place
LAKE LOUISE, CANADA
Conference start date
February 23, 2003
Conference proceedings
JOURNAL OF RHEUMATOLOGY
Issue
8
ISSN
0315-162X